Sitagliptin added to ongoing treatment with metformin improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)

被引：0
|
作者：
Kadowaki, Takashi
Tajima, Naoko
Odawara, Masato
Nishii, Mikio
Nonaka, Kenji
Stein, Peter P.
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A589 / A590
页数：2
相关论文
共 50 条
  • [31] GlyCemic Control with Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
    Fu, Alex Z.
    Qiu, Ying
    Radican, Larry
    DIABETES, 2010, 59 : A612 - A613
  • [32] ACHIEVEMENT OF GLYCEMIC CONTROL BY SITAGLIPTIN, IN PATIENTS WITH NOT WELL REGULATED TYPE 2 DIABETES
    Paschalidou, E.
    Efthimiadis, I.
    Milioni, V.
    Pavlidou, S.
    Vlachopoulou, M.
    Efthimiadis, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [33] Efficacy and safety of sitagliptin or rosiglitazone when added to ongoing metformin therapy in patients with Type 2 diabetes
    Scott, Russell
    Loeys, Tom
    Davies, Michael J.
    Engel, Samuel S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S32 - S32
  • [34] Saxagliptin added to metformin improves glycemic control in patients with type 2 diabetes
    Defronzo, Ralph A.
    Hissa, Miguel
    Blauwet, Mary Beth
    Chen, Roland S.
    DIABETES, 2007, 56 : A74 - A74
  • [35] Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes
    Tajima, Naoko
    Kadowaki, Takashi
    Okamoto, Taro
    Sato, Asako
    Okuyama, Kotoba
    Minamide, Toshiomi
    Ferreira, Juan Camilo Arjona
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (06) : 595 - 604
  • [36] Dapagliflozin Is Safe and Well Tolerated in Older Patients with T2DM
    Mansfield, Traci
    Fioretto, Paola
    Ptaszynska, Agata
    Yavin, Yshai
    Apanovitch, Anne Marie
    Johnsson, Eva
    Parikh, Shamik J.
    List, James F.
    DIABETES, 2014, 63 : A71 - A71
  • [37] COST-EFFECTIVENESS OF SAXAGLIPTIN COMPARED TO SITAGLIPTIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Hutchings, A.
    Tolley, K.
    Achana, F.
    Brereton, N. J.
    Lebmeier, M.
    Mesa, O. A.
    VALUE IN HEALTH, 2011, 14 (07) : A478 - A478
  • [38] Rosiglitazone (RSG) is safe and well tolerated as monotherapy or combination therapy in patients with type 2 diabetes mellitus (T2DM)
    Kreider, M
    Miller, E
    Patel, J
    DIABETES, 1999, 48 : A117 - A117
  • [39] Colesevelam HCl improves glycemic control in patients with type 2 diabetes (T2DM): A pilot study
    Schwartz, Sherwyn L.
    Zieve, Franklin
    Kalin, Marcia
    Jones, Michael R.
    DIABETES, 2006, 55 : A134 - A134
  • [40] Are Chromium (Cr) Supplements Efficacious for Glycemic Control in Type 2 Diabetes (T2DM)?
    Dwyer, Johanna T.
    Costello, R. B.
    Bailey, R. L.
    Wambogo, E.
    FASEB JOURNAL, 2016, 30
12345